More about

Diabetes Device

News
September 12, 2021
3 min read
Save

Time in range — not HbA1c — should guide most diabetes treatment decisions

Time in range — not HbA1c — should guide most diabetes treatment decisions

Clinicians should consider temporary continuous glucose monitoring for any person with diabetes to assess their time spent in the recommended glucose range as an effective guide for treatment decisions, according to a speaker.

News
August 16, 2021
3 min read
Save

‘Identify, configure, collaborate’ framework can optimize use of diabetes technology

‘Identify, configure, collaborate’ framework can optimize use of diabetes technology

Diabetes care and education specialists can use a simple, three-step approach to optimize the way continuous glucose monitoring and other diabetes technologies are used, according to two speakers.

News
August 13, 2021
3 min read
Save

Extra support may alleviate widespread disparities in diabetes technology adoption

Extra support may alleviate widespread disparities in diabetes technology adoption

Diabetes technology uptake continues to be low among people with type 1 diabetes from underrepresented groups, and providers should not overlook patients who may struggle with diabetes management, according to a speaker.

News
August 13, 2021
2 min read
Save

‘We must live our brand’: Diabetes care and education specialist role in challenging times

‘We must live our brand’: Diabetes care and education specialist role in challenging times

The ongoing COVID-19 pandemic has brought with it countless challenges and changes in health care delivery; diabetes care and education specialists must adapt to achieve successful health outcomes, according to a speaker.

News
August 03, 2021
3 min read
Save

Noninvasive glucose monitoring may change future of diabetes management

Noninvasive glucose monitoring may change future of diabetes management

More than 60 noninvasive and minimally invasive bloodless glucose monitoring products are available or in development, and the devices may become important digital tools for people with diabetes, according to a review article.

News
July 06, 2021
2 min read
Save

Smart insulin pen improves glucose levels in poorly controlled diabetes

Smart insulin pen improves glucose levels in poorly controlled diabetes

People with diabetes who have difficulty meeting glycemic targets were better able to manage their glucose levels with a smart insulin pen, according to a speaker at the American Diabetes Association Scientific Sessions.

News
May 24, 2021
3 min read
Save

‘Loop’ artificial pancreas software safe, effective with community support

‘Loop’ artificial pancreas software safe, effective with community support

The Loop open-source system for a do-it-yourself automated insulin delivery system can be initiated with community-developed resources and used safely and effectively by adults and children with type 1 diabetes, real-world data show.

News
May 19, 2021
1 min read
Save

Top in endocrinology: Smart cap for insulin pens, menstrual tracking app for PCOS

Top in endocrinology: Smart cap for insulin pens, menstrual tracking app for PCOS

The FDA cleared a diabetes management system that translates continuously monitored glucose data into on-demand insulin dose recommendations that are displayed on a smart pen-cap screen. It was the top story in endocrinology last week.

News
May 18, 2021
2 min read
Save

CGM offers more benefits than burdens for parents of children with type 1 diabetes

CGM offers more benefits than burdens for parents of children with type 1 diabetes

Parents of children with type 1 diabetes who initiated continuous glucose monitoring during the first month after diagnosis described CGM as beneficial and said they would continue to use it, according to study data.

News
May 13, 2021
3 min read
Save

Continuous ketone monitoring may provide early identification of DKA

Continuous ketone monitoring may provide early identification of DKA

A continuous ketone monitor sensor provided ketone level results similar to a ketone test strip during a 14-day period, according to a study published in the Journal of Diabetes Science and Technology.

View more